Navigation Links
Short Handle Black

ProductsShort Handle Black
Company Richmond Products, Inc.
Item Short Handle Black
Features 
Description Short handle occluders are about 6 inches long.
Info Richmond Products, Inc.Call Richmond Products, Inc. to buy products (US and Canada only; other locations use number below) USACanada1-866-435-4770

Customer Service: 505-275-2406
Web site: http://www.richmondproducts.com

Related medicine products :

1. Weiss Retinal Pick 120 Degree Short
2. Weiss Retinal Pick 90 Degree Short
3. Wilder Lacrimal Dilator - Short
4. Near PT Test Card/Shorthand/PH - BC2204
5. Short system Ventriculoscope
6. Greenberg Short Retractor Arm
7. ACCU-Beam® Surgical Microscope Video Adaptor (Short body)
8. RunWay™ Femoral Left Short Tip
9. Fixed-tip AEM Short Spatula Electrode
10. Short Right Angle Dissector
11. Short Atraumatic Grasper
Breaking Medicine Technology:Hand Surgeons Take Ethics into Their Own Hands 2Hand Surgeons Take Ethics into Their Own Hands 3Hand Surgeons Take Ethics into Their Own Hands 4Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4One in Seven Seniors Faces Social Security Check Cuts in 2010 48435 1One in Seven Seniors Faces Social Security Check Cuts in 2010 48435 2Kuvan Receives Priority Review Status From Health Canada 12563 1Kuvan Receives Priority Review Status From Health Canada 12563 2Kuvan Receives Priority Review Status From Health Canada 12563 3Kuvan Receives Priority Review Status From Health Canada 12563 4PDL BioPharma Announces Record Date for October 1 Dividend Payment 48432 1